Current Radiopharmaceuticals

Papers
(The H4-Index of Current Radiopharmaceuticals is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Lung Cancer and Radiological Imaging26
FDG PET/CT in the Staging of Lung Cancer25
Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas18
In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells16
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)15
PET/CT and the Response to Immunotherapy in Lung Cancer15
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art14
Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial14
Artificial Neural Networks in Cardiovascular Diseases and its Potential for Clinical Application in Molecular Imaging14
Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-4713
Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.12
Alternative and New Radiopharmaceutical Agents for Lung Cancer11
IAEA Activities on 67Cu, 186Re, 47Sc Theranostic Radionuclides and Radiopharmaceuticals11
Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects11
0.043206930160522